Grace Shaw

941 total citations
12 papers, 372 citations indexed

About

Grace Shaw is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Grace Shaw has authored 12 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 8 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Oncology. Recurrent topics in Grace Shaw's work include Prostate Cancer Treatment and Research (10 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and Bone health and treatments (4 papers). Grace Shaw is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and Bone health and treatments (4 papers). Grace Shaw collaborates with scholars based in United States, Italy and Australia. Grace Shaw's co-authors include Kathryn P. Gray, Brandon Bernard, Christopher J. Sweeney, Carolyn Evan, Anis Hamid, Edoardo Francini, Mary‐Ellen Taplin, Philip W. Kantoff, Eliezer M. Van Allen and Massimo Loda and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Urology.

In The Last Decade

Grace Shaw

11 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Grace Shaw United States 5 333 151 113 100 81 12 372
Mai N. Van Netherlands 7 259 0.8× 182 1.2× 68 0.6× 165 1.6× 88 1.1× 13 361
Ruth Riisnaes United Kingdom 5 299 0.9× 231 1.5× 57 0.5× 201 2.0× 90 1.1× 5 431
Anuradha Jayaram United Kingdom 7 332 1.0× 263 1.7× 69 0.6× 108 1.1× 128 1.6× 24 427
Carolyn Evan United States 10 387 1.2× 168 1.1× 78 0.7× 187 1.9× 140 1.7× 20 527
N. Agarwal United States 6 295 0.9× 126 0.8× 53 0.5× 122 1.2× 151 1.9× 14 348
Stefania Kinspergher Italy 12 318 1.0× 112 0.7× 52 0.5× 227 2.3× 97 1.2× 36 428
George Daniel Rădăvoi Romania 8 245 0.7× 104 0.7× 32 0.3× 92 0.9× 145 1.8× 15 343
E. Ileana France 5 314 0.9× 125 0.8× 151 1.3× 64 0.6× 58 0.7× 8 359
Ayse Ӧzatılgan France 8 442 1.3× 148 1.0× 172 1.5× 176 1.8× 81 1.0× 21 495
Oliver Sartor United States 10 346 1.0× 98 0.6× 64 0.6× 90 0.9× 97 1.2× 22 437

Countries citing papers authored by Grace Shaw

Since Specialization
Citations

This map shows the geographic impact of Grace Shaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grace Shaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grace Shaw more than expected).

Fields of papers citing papers by Grace Shaw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grace Shaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grace Shaw. The network helps show where Grace Shaw may publish in the future.

Co-authorship network of co-authors of Grace Shaw

This figure shows the co-authorship network connecting the top 25 collaborators of Grace Shaw. A scholar is included among the top collaborators of Grace Shaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grace Shaw. Grace Shaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
McGregor, Bradley A., Li Zhang, Kathryn P. Gray, et al.. (2020). Bone targeted therapy and skeletal related events in the era of enzalutamide and abiraterone acetate for castration resistant prostate cancer with bone metastases. Prostate Cancer and Prostatic Diseases. 24(2). 341–348. 5 indexed citations
3.
Pomerantz, Mark M., Kim Leitzel, Subrina Farah, et al.. (2020). Plasma IL-8 and PD-L1 and overall survival in metastatic castration-resistant prostate cancer patients (mCRPC).. Journal of Clinical Oncology. 38(15_suppl). e17565–e17565. 3 indexed citations
4.
5.
Francini, Edoardo, Kathryn P. Gray, Grace Shaw, et al.. (2019). Impact of new systemic therapies on overall survival of patients with metastatic castration-resistant prostate cancer in a hospital-based registry. Prostate Cancer and Prostatic Diseases. 22(3). 420–427. 44 indexed citations
6.
Bonet-Carné, Elisenda, Hayley Pye, Aiman Haider, et al.. (2018). Histological Validation of in-vivo VERDICT MRI for Prostate using 3D Personalised Moulds. UCL Discovery (University College London). 2 indexed citations
7.
Hamid, Anis, Kathryn P. Gray, Grace Shaw, et al.. (2018). Compound Genomic Alterations of TP53, PTEN, and RB1 Tumor Suppressors in Localized and Metastatic Prostate Cancer. European Urology. 76(1). 89–97. 178 indexed citations
8.
Francini, Edoardo, Kathryn P. Gray, Wanling Xie, et al.. (2018). Time of metastatic disease presentation and volume of disease are prognostic for metastatic hormone sensitive prostate cancer (mHSPC). The Prostate. 78(12). 889–895. 118 indexed citations
9.
Francini, Edoardo, Kathryn P. Gray, Grace Shaw, et al.. (2018). Impact of new systemic therapies on overall survival (OS) of patients (pts) with metastatic castration resistant prostate cancer (mCRPC) in a hospital-based registry.. Journal of Clinical Oncology. 36(6_suppl). 203–203. 1 indexed citations
10.
Zhang, Li, Kathryn P. Gray, Grace Shaw, et al.. (2018). Bone targeted therapy and skeletal related events in the era of modern therapies for castration resistant prostate cancer with bone metastases.. Journal of Clinical Oncology. 36(15_suppl). 5049–5049. 1 indexed citations
11.
12.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mai N. Van Breakdown of academic impact, for papers by Ruth Riisnaes Breakdown of academic impact, for papers by Anuradha Jayaram Breakdown of academic impact, for papers by Carolyn Evan Breakdown of academic impact, for papers by N. Agarwal Breakdown of academic impact, for papers by Stefania Kinspergher Breakdown of academic impact, for papers by George Daniel Rădăvoi Breakdown of academic impact, for papers by E. Ileana Breakdown of academic impact, for papers by Ayse Ӧzatılgan Breakdown of academic impact, for papers by Oliver Sartor
Rankless by CCL
2026